Reshape Lifesciences Inc (RSLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Operating Expenses | 5,015 | 7,266 | 6,234 | 5,697 | 6,468 |
| Operating Income | -5,015 | -7,266 | -6,234 | -5,697 | -6,468 |
| Interest Expense | 1,635 | 918 | 874 | 678 | 1,501 |
| Other Income | 3,760 | -3,824 | -3,253 | -295 | 147 |
| Pre-tax Income | -2,890 | -12,008 | -10,362 | -6,670 | -7,822 |
| Net Income Continuous | -2,890 | -12,008 | -10,362 | -6,670 | -7,822 |
| Net Income | $-2,890 | $-12,008 | $-10,362 | $-6,670 | $-7,822 |
| EPS Basic Total Ops | -1.65 | -2.40 | -2.07 | -0.30 | -11.70 |
| EPS Basic Continuous Ops | -1.65 | -2.40 | -2.07 | -0.30 | -11.71 |
| EPS Diluted Total Ops | -1.65 | -2.40 | -2.07 | -0.30 | -11.70 |
| EPS Diluted Continuous Ops | -1.65 | -2.40 | -2.07 | -0.30 | -11.71 |
| EBITDA(a) | $-4,103 | $-6,890 | $-5,886 | $-5,418 | $-5,990 |